Learn about our Group strategy and business model
Inspiration Healthcare Group is an ethical Company with high principles in business. We take our responsibilities towards ESG (Environmental, Social and Governance) seriously and are always looking at ways to improve the way we operate our business, especially around issues that effect society as a whole.
We are committed to reducing our impact on the planet wherever possible and undertake regular reviews of our practices to do so. Our aim is to have all operating companies within the Group working towards internationally recognised standards such as ISO14001 with the aim of being accredited to these standards.
We have already initiated some changes to reduce our carbon footprint such as offering electric / hybrid cars as company vehicles to those staff who need company vehicles, we recycle wherever possible and adopt proactive working with suppliers on new materials and production methods to reduce environmental impact. Our operating companies, where applicable, comply to the WEEE (Waste Electric and Electronic Equipment) Regulations in Europe.
We intend to place much greater emphasis on this area of our business over the next few years as we take a more holistic approach to our supply chain and the design of new products. We have an environmental policy which we periodically review to ensure it complies with best practice as well as current legislation.
As a medical technology manufacturer and provider we are deeply embedded in society to improve the outcomes for patients around the world. We are committed to using technology to improving patients lives but will do this in a way that has maximum benefit for society. We have also committed to setting up a charity focused on neonatal research which we hope will have a significant impact on the lives of premature and sick babies in the future.
We are an ethical employer and create a positive working environment for our staff that engages them and develops them. We are an equal opportunities employer and we aim to promote from within the Company wherever possible to give all our staff the chance of improving themselves and support them with relevant training.
We are committed to ethical business practices and ensure all our staff understand their obligations to further ensure that business is conducted in a fair and transparent manner. Our operating companies have codes of conduct for staff for how they should expect to be treated and treat others. As a global supplier we have to respect cultures around the world, recognising that those in different countries have a different way of doing things to us. However, we should never compromise on certain areas of our business and we have policies around issues such as modern slavery (read here), bribery and corruption and money laundering to ensure we are adopting best practice in these areas.
As a Company listed on the Alternative Investment Market of the London Stock Exchange we follow the Quoted Companies Alliance good practice on Governance. Our Board consists of both Executive and Non-executive Directors. The Non-executive Directors are independent and are there to help guide us where needed along the path of best practice of Corporate Governance and ensure everything we do is of the highest level of governance and transparency.
As a medical technology manufacturer and provider we are deeply embedded in society to improve the outcomes for patients around the world. We actively seek to communicate with and support organisations and charities who focus on solving significant issues within healthcare. Our charity committee meet every 3 months to discuss and review causes which we feel can make a real difference to patient’s or their family’s lives. Our team research and engage with various charities, groups and NHS research projects.
If you are involved with a project that aligns with our core values please contact firstname.lastname@example.org with an introduction and overview of your project. For more information please refer to our charitable giving requests procedure.
We have a range of leading-edge products manufactured in-house or to our exacting standards to supply around the world. For information on each product please visit our website.
We view our revenue streams in three distinct areas:
Where we are the legal manufacturer of the product and we control the intellectual property.
Our Group companies have a range of products under their own brand where they are the Legal Manufacturer, placing the product on the market around the world.
We invest in R&D activities across our range of products to ensure our products are at the forefront of medical science. Each Company’s brand is distinct but follows the same ethos of improving patient outcomes using leading edge technology.
Where we sell products from a third party predominantly in the UK and Ireland and in some cases worldwide.
These are products for which we have an agreed relationship with the manufacturer to sell their products in certain territories, mainly the UK and Ireland, although in some instances further afield.
Distributed Products complement our own Branded Product portfolio and add value to our customer proposition as we can offer a more comprehensive product range.
We look to find partners who have great technology in niche areas where we can truly add value for the partner and their products truly add value for us. This win-win approach has served us well and helped us offer a wonderful range of technology from around the world to our customers.
That offers usage and ownership options, maintenance programmes and training to allow users to maximise their experience with our Group’s products.
Not all our customers want the same thing in terms of ownership or maintenance support, some wish to rent / hire equipment, some like to do their own maintenance, others prefer us to do it for them.
Our flexible approach offers short and long-term rental of equipment for a specific patient or period.
We offer planned preventative maintenance directly or through our distribution partners, with genuine spare parts, and technical training.
In our more complex products, we offer different levels of training to ensure that clinicians by the bedside understand the maximum benefits our technology can deliver.
Our Core values are the deeply ingrained principles that guide our business and serve as our cultural cornerstones.
We have chosen not to specialise in one therapy area such as thermoregulation or respiratory medicine, but rather to look at how we can develop technologies that will change the outcome of a patient.
Since our inception, our profile within the research community has always been high. We have supported clinical research by offering training, importing goods for trials and general logistics to help researchers solve medical problems through technology.
New technology with novel features allows us to add to the value proposition of our products, helping differentiate from our competitors and potentially disrupt the market. We expect to see margin improvements through new products and increased growth.
Ultimately the technology and support we deliver to the healthcare professionals that use it daily is centred around the patient. Through customer service, technical support and clinical applications, we focus on delivering the best product we can to the patient at the right time.
We are privileged to work in markets that involve trying to save the lives of some of the most fragile patients. Over 15 million babies are born prematurely every year (approx. 1 in 10 live births) and globally this number is rising. Complications from preterm births are the leading cause of deaths in children under 5 and are estimated to cause over 1 million deaths in 2015 (Source: World Health Organisation).
Not all babies who are premature need resuscitation and not all babies who are resuscitated are premature. Our technology is aimed at giving all babies that need it the best possible start in life.
We also sell our own brand of patient warming products that are used within surgery and a range of distributed products for Infusion Therapy for applications such as parenteral feeding, and chemotherapy.
We sell directly into the UK and Ireland (“Domestic”) and partner with established independent distributors in the rest of the world.
This model gives us the best of both worlds, as we can develop and support the direct market, giving access to Key Opinion Leaders (“KOL”) and first-hand product feedback via a team of clinical sales people. We can use the local knowledge and expertise of like-minded distributors, can sell our products alongside others in their portfolio, value to their customers the way we do domestically.
In all international markets, regulations are becoming more stringent. It is important that we have an expert team to help work with distributors so that localisation of products, such as translations of instructions and other labels, or any specific regulatory requirements are met. This is an important blend of skills and expertise between local distributors, to provide intimate market knowledge, and our own sales, marketing and regulatory team to ensure the products are fit for the market and ensure local compliance.